Please assess the completion status of the following clinical trial:

Trial Title: Epidural Clonidine for Lumbosacral Radiculopathy

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: TREATMENT
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: None
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Residents 18 years or older of Olmsted or contiguous counties and identified as having an acute unilateral radicular syndrome of less than 3 months duration (leg pain\>back, discogenic cause, one or more of the following:~  * Positive Straight Leg Raise (SLR) test~ * Myotomal weakness~ * Dermatomal sensory loss) and with concordant~ * Confirmatory findings on recent MRI or CT myelogram~Exclusion Criteria:~* History of recent spinal trauma~* Cauda equina syndrome (This is a serious neurologic condition in which there is acute loss of function of the lumbar plexus, neurologic elements of the spinal canal below the termination of the spinal cord.)~* Progressive neurological deficit~* Motor deficit~* Pathological or infectious etiology~* Involvement in workers' compensation claim~* History of adverse reaction to corticosteroids, local anesthetic or clonidine~* History of one or more corticosteroid injection(s) (equivalent to 40 mg of triamcinolone acetate) in the preceding 4 months~* Pregnant~* Severe medical disease

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: t

Study Arms:
- Clonidine (Type: EXPERIMENTAL): Transforaminal epidural clonidine injection
- Steroid (Type: ACTIVE_COMPARATOR): Transforaminal epidural steroid injection

Based on this trial design, predict the completion outcome and termination type (if applicable).